purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Umbilical Cord Blood Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Public Cord Blood Banks
1.2.3 Private Cord Blood Banks
1.3 Market by Application
1.3.1 Global Stem Cell Umbilical Cord Blood Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Cancer/ Oncology Diseases
1.3.3 Chronic Leukemia
1.3.4 Myelodysplastic Syndrome
1.3.5 Blood Diseases
1.3.6 Beta Thalassemia
1.3.7 Sickle Cell Disease
1.3.8 Wiskott-Aldrich
1.3.9 Hurler Syndrome
1.3.10 Sanfilippo Syndrome
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Umbilical Cord Blood Market Perspective (2018-2030)
2.2 Stem Cell Umbilical Cord Blood Growth Trends by Region
2.2.1 Stem Cell Umbilical Cord Blood Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Stem Cell Umbilical Cord Blood Historic Market Size by Region (2018-2023)
2.2.3 Stem Cell Umbilical Cord Blood Forecasted Market Size by Region (2023-2030)
2.3 Stem Cell Umbilical Cord Blood Market Dynamics
2.3.1 Stem Cell Umbilical Cord Blood Industry Trends
2.3.2 Stem Cell Umbilical Cord Blood Market Drivers
2.3.3 Stem Cell Umbilical Cord Blood Market Challenges
2.3.4 Stem Cell Umbilical Cord Blood Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Umbilical Cord Blood Players by Revenue
3.1.1 Global Top Stem Cell Umbilical Cord Blood Players by Revenue (2018-2023)
3.1.2 Global Stem Cell Umbilical Cord Blood Revenue Market Share by Players (2018-2023)
3.2 Global Stem Cell Umbilical Cord Blood Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Umbilical Cord Blood Revenue
3.4 Global Stem Cell Umbilical Cord Blood Market Concentration Ratio
3.4.1 Global Stem Cell Umbilical Cord Blood Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Umbilical Cord Blood Revenue in 2022
3.5 Stem Cell Umbilical Cord Blood Key Players Head office and Area Served
3.6 Key Players Stem Cell Umbilical Cord Blood Product Solution and Service
3.7 Date of Enter into Stem Cell Umbilical Cord Blood Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Umbilical Cord Blood Breakdown Data by Type
4.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Type (2018-2023)
4.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Type (2023-2030)
5 Stem Cell Umbilical Cord Blood Breakdown Data by Application
5.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Application (2018-2023)
5.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Stem Cell Umbilical Cord Blood Market Size (2018-2030)
6.2 North America Stem Cell Umbilical Cord Blood Market Size by Country (2018-2023)
6.3 North America Stem Cell Umbilical Cord Blood Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Stem Cell Umbilical Cord Blood Market Size (2018-2030)
7.2 Europe Stem Cell Umbilical Cord Blood Market Size by Country (2018-2023)
7.3 Europe Stem Cell Umbilical Cord Blood Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size (2018-2030)
8.2 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Country (2018-2023)
8.3 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Stem Cell Umbilical Cord Blood Market Size (2018-2030)
9.2 Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2018-2023)
9.3 Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size (2018-2030)
10.2 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2018-2023)
10.3 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Advanced Cell Technology
11.1.1 Advanced Cell Technology Company Detail
11.1.2 Advanced Cell Technology Business Overview
11.1.3 Advanced Cell Technology Stem Cell Umbilical Cord Blood Introduction
11.1.4 Advanced Cell Technology Revenue in Stem Cell Umbilical Cord Blood Business (2018-2023)
11.1.5 Advanced Cell Technology Recent Development
11.2 California Stem Cell
11.2.1 California Stem Cell Company Detail
11.2.2 California Stem Cell Business Overview
11.2.3 California Stem Cell Stem Cell Umbilical Cord Blood Introduction
11.2.4 California Stem Cell Revenue in Stem Cell Umbilical Cord Blood Business (2018-2023)
11.2.5 California Stem Cell Recent Development
11.3 Cytori Therapeutics
11.3.1 Cytori Therapeutics Company Detail
11.3.2 Cytori Therapeutics Business Overview
11.3.3 Cytori Therapeutics Stem Cell Umbilical Cord Blood Introduction
11.3.4 Cytori Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2018-2023)
11.3.5 Cytori Therapeutics Recent Development
11.4 Mesoblast Limited
11.4.1 Mesoblast Limited Company Detail
11.4.2 Mesoblast Limited Business Overview
11.4.3 Mesoblast Limited Stem Cell Umbilical Cord Blood Introduction
11.4.4 Mesoblast Limited Revenue in Stem Cell Umbilical Cord Blood Business (2018-2023)
11.4.5 Mesoblast Limited Recent Development
11.5 Opexa Therapeutics
11.5.1 Opexa Therapeutics Company Detail
11.5.2 Opexa Therapeutics Business Overview
11.5.3 Opexa Therapeutics Stem Cell Umbilical Cord Blood Introduction
11.5.4 Opexa Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2018-2023)
11.5.5 Opexa Therapeutics Recent Development
11.6 Athersys
11.6.1 Athersys Company Detail
11.6.2 Athersys Business Overview
11.6.3 Athersys Stem Cell Umbilical Cord Blood Introduction
11.6.4 Athersys Revenue in Stem Cell Umbilical Cord Blood Business (2018-2023)
11.6.5 Athersys Recent Development
11.7 Geron Corporation
11.7.1 Geron Corporation Company Detail
11.7.2 Geron Corporation Business Overview
11.7.3 Geron Corporation Stem Cell Umbilical Cord Blood Introduction
11.7.4 Geron Corporation Revenue in Stem Cell Umbilical Cord Blood Business (2018-2023)
11.7.5 Geron Corporation Recent Development
11.8 Neostem
11.8.1 Neostem Company Detail
11.8.2 Neostem Business Overview
11.8.3 Neostem Stem Cell Umbilical Cord Blood Introduction
11.8.4 Neostem Revenue in Stem Cell Umbilical Cord Blood Business (2018-2023)
11.8.5 Neostem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details